Acute pancreatitis in liver transplant hospitalizations: Identifying national trends, clinical outcomes and healthcare burden in the United States

Table 3 Comparative analysis of hospitalization characteristics for liver and non-liver transplant hospitalizations with acute pancreatitis in the United States from 2007–2019, n (%)

Outcomes	Liver transplant hospitalizations with acute pancreatitis	Non-liver transplant hospitalizations with acute pancreatitis	P value
Total number of hospitalizations	6863	5649980
Mean age ± standard error (yr)	53.50 (0.04)	52.55 (0.39)	0.017
Age group (yr)			< 0.0001
18–34	12.38	16.20
35–49	22.91	26.36
50–64	46.29	29.97
65–79	17.55	18.43
≥ 80	0.86	9.03
Gender			0.0046
Male	55.43	51.13
Female	44.57	48.87
Race			≤ 0.0001
White	67.91	64.57
Black	10.85	16.11
Hispanic	13.11	13.12
Asian	3.95	2.30
Other	4.16	3.90
Charlson comorbidity index			< 0.0001
CCI = 1	29.53	28.27
CCI = 2	19.02	13.65
CCI ≥ 3	51.46	19.76
Hospital region			0.0753
Northeast	16.71	16.45
Midwest	24.80	22.02
South	35.10	40.16
West	23.38	21.37
Hospital bed-size			< 0.0001
Small	9.49	17.96
Medium	21.04	28.13
Large	69.47	53.91
Hospital location and teaching status			< 0.0001
Rural	7.15	12.46
Urban nonteaching	23.12	36.23
Urban teaching	69.73	51.32
Disposition			< 0.0001
Routine (Home)	76.26	77.39
Transfer to short-term hospital	7.30	3.10
Transfer to another type of facility (Includes SNF and ICF)	4.20	7.64
Home health care	8.89	6.69
Discharge against medical advice	1.98	3.00

CCI: Charlson comorbidity index; ICF: Intermediate care facility; SNF: Skilled nursing facility.